AP1638A - Peptide mimics of conserved gonococcal epitopes and methods and compositions using them. - Google Patents

Peptide mimics of conserved gonococcal epitopes and methods and compositions using them.

Info

Publication number
AP1638A
AP1638A APAP/P/2002/002511A AP2002002511A AP1638A AP 1638 A AP1638 A AP 1638A AP 2002002511 A AP2002002511 A AP 2002002511A AP 1638 A AP1638 A AP 1638A
Authority
AP
ARIPO
Prior art keywords
compositions
methods
peptide mimics
epitopes
conserved
Prior art date
Application number
APAP/P/2002/002511A
Other languages
English (en)
Other versions
AP2002002511A0 (en
Inventor
Peter A Rice
Jutamas Ngampasutadol
Sunita Gulati
Original Assignee
Peter A Rice
Jutamas Ngampasutadol
Sunita Gulati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter A Rice, Jutamas Ngampasutadol, Sunita Gulati filed Critical Peter A Rice
Publication of AP2002002511A0 publication Critical patent/AP2002002511A0/xx
Application granted granted Critical
Publication of AP1638A publication Critical patent/AP1638A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/2002/002511A 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them. AP1638A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16249199P 1999-10-29 1999-10-29
PCT/US2000/029749 WO2001032692A2 (fr) 1999-10-29 2000-10-27 Mimetiques peptidiques d'epitopes gonococciques conserves, techniques et compositions les utilisant

Publications (2)

Publication Number Publication Date
AP2002002511A0 AP2002002511A0 (en) 2002-06-30
AP1638A true AP1638A (en) 2006-07-20

Family

ID=22585848

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2002/002511A AP1638A (en) 1999-10-29 2000-10-27 Peptide mimics of conserved gonococcal epitopes and methods and compositions using them.

Country Status (7)

Country Link
CN (2) CN101638433B (fr)
AP (1) AP1638A (fr)
AU (1) AU785022B2 (fr)
HK (1) HK1141034A1 (fr)
NZ (2) NZ532271A (fr)
OA (1) OA12315A (fr)
WO (1) WO2001032692A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101899097B (zh) * 2010-07-07 2012-02-01 南方医科大学 一种b血型抗原表位模拟肽及其应用
CN101899096B (zh) * 2010-07-07 2012-07-04 南方医科大学 一种a血型抗原表位模拟肽及其应用
EP4034155A4 (fr) * 2019-09-23 2024-01-10 University of Massachusetts Mimétiques peptidiques multi-antigènes d'épitopes de lipo-oligosaccharides (los) gonococciques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022479A1 (fr) * 1993-04-06 1994-10-13 Trustees Of Health & Hospitals Of The City Of Boston Anticorps anti-idiotypiques gonococciques et procedes et compositions les utilisant
WO1999040189A2 (fr) * 1998-02-09 1999-08-12 Genset ADNc CODANT DES PROTEINES SECRETEES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022479A1 (fr) * 1993-04-06 1994-10-13 Trustees Of Health & Hospitals Of The City Of Boston Anticorps anti-idiotypiques gonococciques et procedes et compositions les utilisant
WO1999040189A2 (fr) * 1998-02-09 1999-08-12 Genset ADNc CODANT DES PROTEINES SECRETEES

Also Published As

Publication number Publication date
AP2002002511A0 (en) 2002-06-30
NZ518915A (en) 2004-05-28
WO2001032692A3 (fr) 2002-03-07
CN1409725A (zh) 2003-04-09
OA12315A (en) 2006-05-15
HK1141034A1 (en) 2010-10-29
WO2001032692A2 (fr) 2001-05-10
CN101638433B (zh) 2014-10-29
CN1409725B (zh) 2012-06-06
CN101638433A (zh) 2010-02-03
NZ532271A (en) 2006-03-31
AU1242001A (en) 2001-05-14
AU785022B2 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
WO2004024097A8 (fr) Compositions et methodes de traitement de maladies de nature immune
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
WO2005019258A3 (fr) Compositions et methodes de traitement de maladies relatives au systeme immunitaire
BR9814487A (pt) "vacina"
BR9812139A (pt) Vacina
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
MY144612A (en) Nogo-a neutralising immunoglobulins for treatment of neurological diseases
EP1194164B8 (fr) Peptides proteiniques du prion et utilisations associees
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
WO2004024068A3 (fr) Nouvelles composition et methodes servant au traitement de maladies associees au systeme immunitaire
WO2000053758A3 (fr) Compositions et methodes de traitement des maladies immunitaires
ZA200501054B (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use.
NZ324500A (en) Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
IL189629A0 (en) Compositions containing human ctla-4 antibodies
WO1998057994A3 (fr) Anticorps opsoniques, monoclonaux protecteurs, et chimeres specifiques a l'acide lipoteichoique des bacteries gram positif
IL201889A (en) Medication for the treatment of vaccine-related disorders containing antibodies that specifically recognize the nk 1.1 antigen or cd56 antigen expressed by nk t cells
WO2000018351A3 (fr) Produits aglyco et utilisation de ceux-ci
WO2000073452A3 (fr) Compositions et methodes de traitement de maladies liees a l'immunite
HK1016017A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
EP1423137A4 (fr) Stereo-isomeres de lipopeptide, methodes de preparation afferentes et intermediaires utiles
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
EP1556513A4 (fr) Compositions et methodes pour traiter une maladie a mediation par le papillomavirus humain (hpv)
AU2002310474A1 (en) Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
WO2003059260A3 (fr) Anticorps monoclonaux et chimeriques opsoniques specifiques de l'acide lipoteichoique de bacteries gram-positif